Leading the
global fight
against cancer
 
 

Union for International Cancer ControlUICC

"The Union for International Cancer Control (UICC) unites and supports the cancer community to reduce the global cancer burden, to promote greater equity, and to ensure that cancer control continues to be a priority in the world health and development agenda."

 
Our main missions
icon_convening-orange.png
Convening

Convening the global cancer control community through our keystone events

icon_capacity-building-orange_0.png
Capacity Building

Developing capacity building initiatives to strengthen the cancer community

icon_advocacy-orange.png
Advocacy

Promoting cancer in the global health and development agendas

Our key platforms
icon_wcd-blue.png
World Cancer Day 2024 – 4 Feb

360

days

Latest news and updates
Our news and updates
Branded World Cancer Day flag on the Mont Blanc bridge in Geneva for World Cancer Day 2023
8 February 2023
News

World Cancer Day 2023 demonstrates the power of collective action

The second year of the “Close the care gap” campaign saw hundreds of public events, social media campaigns and ‘5k Challenges’ taking place around the world on 4 February.

Sarawak Breast Cancer Support Group (SBCSG) - 2012 Sri Aman Breast Cancer Awareness Road Show
7 February 2023
Blog

Shunted system: breast cancer in the marginalised populations of Borneo

Drawing on her mother’s breast cancer diagnosis and the example of Sarawak, Dr Lim looks at the barriers to early detection and care that exist more widely in Malaysia due to remote living, poor financial means, lack of screening services and cultural beliefs, and what actions can be taken, notably by the government, to close this care gap.

Cropped head of a white male eating burger, fries, soda and beer in front of his computer.
3 February 2023
News

Commercial interests drive millions of cancer deaths

Marking World Cancer Day on 4 February, UICC calls on governments around the world to prioritise four policy actions to reduce preventable cancers caused by tobacco use and the consumption of alcohol and ultra-processed foods.

Social media banner promoting the World Cancer Day Equity Report with images from the WCD campaign and inside page of the report
2 February 2023
News

World Cancer Day Equity Report highlights barriers to cancer care

In a new report, present and past members of the UICC Board of Directors write about the disparities in cancer care in their respective countries and regions and what is being done to close the care gap.

Spotlight on
Jim Tennermann, who has been diagnosed eight times with cancer, says it is important not to dive into self-pity but instead engage in a passion; his are guitar and cycling.
9 January 2023
News

Podcast "Let's Talk Cancer" – Overcoming eight cancer diagnoses

In the lead-up to World Cancer Day, listen to the unique story of Jim Tennermann, who has been diagnosed with cancer eight times since first discovering he had a brain tumour almost 30 years ago.

World Cancer Day 2022-2024 campaign image featuring a man and woman of different ethnicities.
27 January 2023
News

JCO special World Cancer Day issue on equitable access to cancer care

Ahead of World Cancer Day, JCO Global Oncology (JCO GO) is showcasing previously published articles on how to address disparities in access to cancer services globally.

Our Partners
AECC logo.png
Asociación Española Contra el Cancer (AECC)

The Asociación Española Contra el Cáncer (AECC) (Spanish Association Against Cancer) is a non-profit, private social entity which has been declared of public utility. It was founded in 1953. The mission of the AECC is the fight against cancer leading the efforts of the Spanish society to decrease the impact of this disease and to improve the people’s quality of life. Four main strategic pillars guide the activities of the association: information & awareness, cancer patients support, research, and advocacy & lobbying. It is a nation wide organisation with 52 provincial delegations and more than 2.000 local delegations. The association counts on more than 109.000 members, 14.000 volunteers and 730 workers to develop its activities. In 1971, the AECC established its Scientific Foundation which main purpose is to improve cancer research in Spain. The Asociacion Española Contra el Cancer became a full UICC member in 1962.

bd_color_rgb_2_25.jpg
Becton, Dickinson and Company

Becton, Dickinson and Company (BD) is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes.

Bristol-Myers Squibb Logo
Bristol-Myers Squibb (BMS)

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.

CRUK
Cancer Research UK

Cancer Research UK is the world’s largest independent funder of cancer research. Its vision is to bring forward the day when all cancers are cured. Since 1902 CRUK has found new ways to prevent, diagnose and treat cancer. CRUK-funded scientists’ pioneered early radiotherapy, developed some of the world’s top cancer drugs and discovered the tumour suppressor gene, p53. Its work has saved millions of lives across the world. CRUK invests $500m annually in world-leading research across all 200 different types of cancer, working with partners in Europe, North America and Asia to accelerate research progress. It provides information to those affected by cancer, works to increase cancer awareness, and uses its powerful, independent voice to keep cancer at the top of the political agenda. CRUK funds some of the world’s leading experts in tobacco research and is a key player in international tobacco control. It became a full UICC member in 1986.

Cancerfonden logo
Cancerfonden

Founded in 1951 to support cancer research, the Swedish Cancer Society is an independent non-profit organization with the vision of finding cures for cancer. The overall aim of the Society is to achieve a higher survival rate and a reduction in the incidence of cancer. Their main task is to raise and distribute money for cancer research. As one of the largest financiers of cancer research in Sweden, the Swedish Cancer Society essentially acts as a national research council. Thanks to the organization’s extensive knowledge about cancer, the Swedish Cancer Society is also active in areas such as public opinion and spreading knowledge about cancer, as well as results of cancer research.

Daiichi Sankyo.jpg
Daiichi Sankyo

Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose “to contribute to the enrichment of quality of life around the world. In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs.

With more than 120 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an “Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.” For more information, please visit www.daiichisankyo.com.

KWF-DutchCancerSociety-RGB (1).jpg
Dutch Cancer Society

The Dutch Cancer Society is a nation-wide organization for cancer control in the Netherlands. The society was funded in 1949 by Queen Wilhelmina. Her granddaughter, Her Royal Highness Princess Beatrix, is the current patron. The Dutch Cancer Society’s ideal world is one in which nobody dies from cancer ever again. We want fewer people to get cancer, more people to cure, and patients to have a better quality of life, during and after the disease. That’s why we fund and facilitate scientific research, influence policy, and share our knowledge about cancer and its treatment. To make this possible, we raise funds and establish links with other parties involved in cancer control, both here in the Netherlands and elsewhere. The Dutch Cancer Society is entirely dependent on community involvement and donations. Over 100.000 volunteers support the Dutch Cancer Society whether it comes to local or nation-wide fundraising, scientific or policy advice in several councils and committees. We can rely on nearly 1.500 local committees that organize fundraising activities e.g. our annual door-to-door campaign to raise funds for the fight against cancer. The Dutch Cancer Society is supported by over 1 million donors. The Dutch Cancer Society’s office is located in Amsterdam; our professional staff amounts to 198 staff members.

Fondation Philantropia
Fondation Philantropia

An umbrella foundation associated with the bank Lombard Odier and a registered charity, Fondation Philanthropia has been helping its donors bring their philanthropic initiatives to fruition in all areas of social responsibility since 2008. It provides philanthropic expertise and support to those who wish to develop a philanthropic project in line with their background, desires and ambitions. The Foundation offers its donors a legal, financial and philanthropic framework for made-to-measure projects.

The Foundation now operates more than 20 personal funds and has received over 115 million Swiss francs in donations, of which over a third has already been distributed or committed. Its donors have been highly committed to the fight against cancer, with over 15 million spent on the cause.

hologic logo.png
Hologic

Hologic, Inc. is a global medical technology innovator primarily focused on improving women’s health and well-being through early detection and treatment. Its advancements include leadership in providing diagnostic solutions for cervical cancer screening, sexually transmitted infections, respiratory illnesses, and the virus that causes COVID-19; invention of the world’s first commercial 3D mammography system to fight breast cancer; and minimally invasive surgical technologies for uterine fibroids and abnormal uterine bleeding. The company champions women through the Hologic Global Women’s Health Index, which provides a science-backed data roadmap for improving women’s well-being, and Project Health Equality, which elevates awareness, research insights and access to quality care for underserved women.

Institut National du Cancer
Institut National du Cancer

The French National Cancer Institute (INCa) was established under the French Public Health Act of August 9, 2004, as the State health and science agency specialised in cancer control. The Institute operates under the supervision of the French Ministry of Health and Solidarities and the French Ministry of Higher Education, Research and Innovation. It provides an integrated approach encompassing all cancer-control aspects (health, scientific, social and economic) and intervention areas (prevention, screening, care, research) to benefit patients and their relatives. The Institute is also a trusted source of evidence-based information, providing reliable advice on cancer control to government and guidance to health professionals and the community. The Institute drives the implementation of the French decennial strategy against cancer (2021-2030): it plays a pivotal role in maximising coordination amongst cancer control stakeholders to enhance impact.

kom-op-tegen-kanker-logo-vector.png
Kom Op Tegen Kanker – Stand Up To Cancer Flanders

‘You have cancer.’ More than 40,000 Flemish people are given this diagnosis every year. 1 in 4 women develop the disease before the age of 75. In men it is even 1 in 3. Fortunately, survival rates are up. This means increasingly more people live with the consequences of cancer. In Flanders more than a quarter of a million already. Kom op tegen Kanker (Stand up to Cancer), an independent ngo and non-profit organisation, plays a leading role in this and is the point of contact in the fight against cancer in Flanders and Brussels. Our dream? A world in which we no longer lose loved ones to cancer. But we're not there yet. We will fight until this dream becomes reality. How? By preventing and fighting cancer. But also by alleviating the effects of cancer and advocating a better cancer policy. To be able to do this, we mobilise as many people as possible to fight against cancer: as care volunteer, campaigner or donor.  Find out more about our organisation and how you can help on komoptegenkanker.be.  

LP56860-lrp-retail-brand-white-logo (002).png
La Roche-Posay

N°1 dermatologist recommended skincare brand worldwide, La Roche-Posay’s mission is to offer life-changing dermatological skincare solutions. Recommended by 90,000 dermatologists worldwide*, La Roche-Posay was created by a pharmacist in 1975. The brand is today present in over 60 countries. It offers a unique range of daily skincare developed for every skin type to complement their dermatological treatments and promote good skincare practices adapted to each skin concern. The brand develops formulas with its exclusive Selenium-rich water, also used at its Thermal Center, the first Dermatology Center in Europe, due to its antioxidant and soothing properties. The products are developed using a strict formulation charter with a minimal number of ingredients and are formulated at optimal concentrations. Additionally, La Roche-Posay products undergo stringent clinical testing for efficacy and safety, even on sensitive skin.  The La Roche-Posay Cancer Support program includes two pillars related to the fight against cancer: Fight With Care to improve patients’ quality of life during all cancer treatment for better adherence and higher chances of healing, and Save Your Skin to prevent skin cancer specifically. On both topics, the brand is committed to raising awareness, training health care professional and the general public, and helping patients by supporting NGOs’ projects beyond skincare. Since 2019, the Fondation La Roche-Posay is also committed to improving the life of children with cancer and their families. In 2020, the brand went a step further in its commitment to protect the planet. Besides launching the first eco-designed tubes integrating cardboard, the brand announced a long-term plan to reduce its use of virgin plastic by 70% in 2025.

For additional information about La Roche-Posay, visit www.laroche-posay.com.

*source: survey on the dermocosmetic market carried out by iqvia and other partners (ipsos, tns) between september 2017 and august 2018 among dermatologists in 62 countries.

 

MSD be well
MSD (Merck & Co)

For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bring forward medicines and vaccines for the world’s most challenging diseases.  MSD is a trade name of Merck & Co., Inc., Kenilworth, N.J., USA. Through their prescription medicines, vaccines, biologic therapies, and animal health products, they work with customers and operate in more than 140 countries to deliver innovative health solutions. MSD also demonstrates their commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.

National Cancer Institute (NCI)
National Cancer Institute (NCI)

The National Cancer Institute (NCI) is the federal government's principal agency for cancer research and training. The NCI coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.

Novartis logo
Novartis Oncology

Novartis Oncology is a global leader in transforming outcomes for people with cancer. We offer a wide range of innovative therapies to help meet patient needs and have one of the strongest, most productive pipelines in the industry. Our research is driven by a distinctive scientific and clinical strategy focused on precision oncology – understanding how cancer develops on a genomic level and developing drugs that hone in on those targets.

Pfizer logo
Pfizer

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development and manufacture of healthcare products. Our global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer healthcare products. We work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We collaborate with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world.

Roche logo
Roche

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims for improving patient access to medical innovations by working with all relevant stakeholders. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines.

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide.

Sanofi
Sanofi

Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.

UICC Japan
UICC Japan

The Japan National Committee for UICC is a group of Japanese organisations that are members of the Union for International Cancer Control (UICC), gathered to support the UICC to strive to realise the World Cancer Declaration. Currently UICC-Japan is composed of 29 full Japanese UICC members, including major cancer specialists in Japan, cancer centres, research institutes, research funds, hospitals and cancer associations.

Give us
your support
 

Are you organising a cancer-related event and would like to feature it in our events section?

 

Are you interested in joining a dynamic network of over 1,000 members?

 

Would you like to support the work of UICC and its member organisations?